(NASDAQ: DWTX) Dogwood Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33%.
Dogwood Therapeutics's earnings in 2026 is -$25,179,614.On average, 4 Wall Street analysts forecast DWTX's earnings for 2026 to be -$34,118,412, with the lowest DWTX earnings forecast at -$35,590,187, and the highest DWTX earnings forecast at -$32,111,447. On average, 4 Wall Street analysts forecast DWTX's earnings for 2027 to be -$28,074,579, with the lowest DWTX earnings forecast at -$29,221,417, and the highest DWTX earnings forecast at -$26,491,944.
In 2028, DWTX is forecast to generate -$29,244,353 in earnings, with the lowest earnings forecast at -$34,840,920 and the highest earnings forecast at -$22,879,406.